Ascot

Quick links to important sections

Ascot

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ascot

Quick Facts

Property Description
Active Ingredients Acetylsalicylic Acid (Aspirin), Ascorbic Acid (Vitamin C)
Form Oral Dosage Form (Tablet)
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID) + Vitamin Supplement
Common Use Symptomatic relief of pain and fever in adults
Type Fixed-Dose Combination Preparation

Defining Ascot: Combination and Classification

Ascot is a medicinal product formulated as a Fixed-Dose Combination Preparation for oral administration, typically provided as a tablet. This preparation is primarily classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), supplemented by a Vitamin Supplement due to its composition.

The inclusion of two active components in a single unit is a key feature, positioning it as a multi-action product. Its classification as an NSAID is rooted in the action of Acetylsalicylic Acid, which is clinically recognized for its swift analgesic and antipyretic efficacy. The design is intended to offer patients the convenience of addressing both symptomatic pain and nutritional needs simultaneously, differentiating it from single-ingredient analgesics.


Active Ingredients and Origin of Ascot

The active identity of Ascot relies on Acetylsalicylic Acid and Ascorbic Acid (Vitamin C). Acetylsalicylic Acid is a widely recognized synthetic compound responsible for the core symptomatic relief. In contrast, Ascorbic Acid is an essential micronutrient known for its antioxidant and supportive properties, commonly used during periods of illness.

Pharmacological studies confirm that Acetylsalicylic Acid is effective in managing acute mild to moderate pain. This indicates the medicine is designed for robust and reliable symptom reduction. The preparation's status as an Over-The-Counter (OTC) product in many regions further shapes its positioning as an accessible option for adult self-care.


General Purpose of the Ascot Combination

The general therapeutic purpose of Ascot is to provide comprehensive symptomatic relief by managing both discomfort and fever while supporting general cellular function. This combination is typically used for the relief of general aches, pains, and fever commonly associated with ailments like the flu or cold.

The combined action of a systemic analgesic with Vitamin C aligns with the recognized role of Ascorbic Acid in immune function. Therefore, this medicine is intended to offer integrated relief and supportive care in one preparation, providing a supportive aid during periods of physical distress.

What side effects are possible with Ascot?

Possible Side Effects and Safety Information

The safety profile of Ascot, a fixed-dose combination containing Acetylsalicylic Acid (NSAID) and Ascorbic Acid (Vitamin C), is primarily defined by the documented risks associated with the NSAID component, as categorized by official regulatory agencies.

Adverse Reaction Scope and Classification

Adverse reactions are formally grouped by the system-organ class involved, with common effects often relating to the Gastrointestinal Disorders system. These common effects include manifestations such as heartburn, nausea, and abdominal pain. Less frequently, uncommon effects like general skin reactions may occur. More seriously, rare documented events include the development of gastrointestinal ulcers, which, in severe instances, may lead to perforation, and gastrointestinal bleeding

.

Bleeding is a key documented risk involving the Blood and Lymphatic System, with the effect on platelet function potentially persisting for several days following use.

Serious Safety Considerations and Constraints

Regulatory warnings highlight critical, potentially life-threatening events. One serious risk is Reye's syndrome, a rare but severe illness noted when acetylsalicylic acid is given to children or teenagers recovering from viral infections. Other serious reactions include severe hypersensitivity reactions and acute renal failure or hepatic impairment.

Specific patient safety constraints are detailed in the official label. Use is contraindicated in individuals with severe hepatic or renal insufficiency and those with an active peptic ulcer. Furthermore, habitual long-term use of analgesics is officially associated with the risk of chronic kidney damage, known as analgesic nephropathy.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documentation defines the overdose profile for Ascot, focusing on the acute toxicity of Acetylsalicylic Acid (Salicylate). Overdose presentations, known as Salicylism, range from mild to life-threatening.

Documented Overdose Manifestations

Classification Symptoms and Signs (Regulatory-Listed)
Early/Mild Tinnitus (ringing in the ears), Nausea, Vomiting, Hyperventilation, Dizziness.
Severe/Life-Threatening Confusion, Lethargy, Seizures, Coma, Severe Metabolic Acidosis, Acute Renal Failure.

Required Emergency Actions

The official label mandates that a patient seek immediate medical attention or contact a Poison Control Center immediately for any suspected overdose. Urgent medical care is required for all symptomatic patients and following an acute ingestion exceeding 150 mg/kg.

Regulatory management procedures include immediate administration of Activated Charcoal and procedures for enhanced elimination, such as Urinary Alkalinization or Hemodialysis. No specific antidote is known for Salicylate toxicity. Continuous hospital monitoring of serial blood salicylate levels and acid-base status is officially required.

Therapeutic Uses of Ascot

What Ascot Treats: Main Uses and Benefits

Relief for Acute Systemic Illness Symptoms

This medication is relevant in conditions characterized by periods of heightened symptoms that involve a cluster of symptoms related to systemic imbalance, such as those associated with the common cold and influenza. It is applied in addressing symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort and generalized body aches, muscular pain, and malaise. The primary active ingredient is used for managing symptoms related to systemic imbalance and mild to moderate pain. This supports the patient during difficult episodes by easing distress during phases when symptoms become more noticeable.


Management of Mild to Moderate Pain and Fever

Ascot is applied within clinical settings that involve acute or unstable symptom patterns, offering short-term symptomatic assistance to manage mild to moderate pain and elevated body temperature (pyrexia). This includes treating manifestations such as headache, dental pain, joint discomfort, and menstrual pain (dysmenorrhea). This contributes to improved day-to-day comfort during periods of heightened symptoms and may assist with managing functional stability when symptoms interfere with routine activities.


Supportive Therapeutic Benefit in Symptom-Driven Contexts

The combination is relevant when supportive symptom management is appropriate, providing an applied benefit during phases where the patient experiences heightened discomfort. The inclusion of the vitamin component is considered relevant for supporting general well-being during symptomatic phases. This offers symptomatic relief that may help patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Acute Symptom Cluster
Applied in conditions involving inflammatory or irritative processes that cause acute symptoms.
Used for managing symptoms related to systemic imbalance and pain that interfere with daily functioning.
Provides supportive relief when short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus overview on Aspirin

Eligibility and Restrictions for Use

The eligibility for Ascot (Atorvastatin) is strictly defined by government regulatory documents, focusing on patient safety and specific physiological states.

Contraindications and Exclusions

The medicine is contraindicated and must not be used in the following populations:

  • Patients with active liver disease, including unexplained persistent elevations in serum transaminases.
  • Women who are pregnant or breastfeeding.
  • Women of childbearing potential not using effective contraception.
  • Individuals with a known hypersensitivity to Atorvastatin or any of its components.

Conditional and Age-Related Eligibility

Population Group Eligibility Rule (Official Basis)
Pediatric Patients Approved for those mathbfgeq 10 years for specific types of familial hypercholesterolemia; use is not established for children younger than 10.
Renal Impairment Eligible for use, but requires caution as it is a risk factor for myopathy/rhabdomyolysis.
Elderly Patients Eligible for use, but age mathbfgeq 65 is listed as a risk factor for myopathy.

Eligibility is also restricted when co-administered with certain strong drug inhibitors (e.g., cyclosporine), which imposes a maximum dose limit according to regulatory warnings.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation establishes specific interaction constraints for the combination of Acetylsalicylic Acid and Ascorbic Acid. Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Ketorolac, or with Anticoagulants (e.g., Warfarin, Heparin) is either restricted or formally prohibited due to an additive pharmacodynamic effect that significantly increases the official risk of bleeding and gastrointestinal adverse events. Co-administration with Methotrexate may increase its plasma concentration and toxicity.

Administration Timing and Substance Interaction

Specific timing requirements are mandated to avoid interference. Immediate-release Ibuprofen must be administered at least 30 minutes after or at least 8 hours before the Acetylsalicylic Acid component (when used at low doses for its anti-platelet effect). Ascorbic Acid can affect the body’s absorption of substances, notably increasing the uptake of Aluminum from antacids, requiring a separation of at least two to four hours between administrations. Furthermore, the combination of Acetylsalicylic Acid with chronic, heavy Alcohol use is explicitly linked to an increased risk of gastrointestinal bleeding. Official warnings also extend to certain herbal products (e.g., Ginkgo, Garlic) which may increase the risk of hemorrhage.

Mechanism of Action

Ascot (a treatment regimen comprising amlodipine and perindopril) modulates the cardiovascular system through two distinct, yet complementary, pharmacodynamic mechanisms. Amlodipine functions as a dihydropyridine calcium channel blocker, selectively interacting with the L-type voltage-gated calcium channels primarily located in vascular smooth muscle cells. This antagonistic action prevents the transmembrane influx of extracellular calcium ions, reducing the intracellular calcium concentration. The subsequent decrease in actin-myosin cross-bridge formation leads to vascular smooth muscle relaxation, resulting in systemic vasodilation and a reduction in total peripheral resistance.

Perindopril operates as an angiotensin-converting enzyme (ACE) inhibitor. It is a competitive inhibitor that binds to the active site of the ACE enzyme, blocking the conversion of the inactive decapeptide angiotensin I into the potent vasoconstrictor and aldosterone-releasing agent, angiotensin II. This inhibition lowers circulating and tissue levels of angiotensin II. The reduction in angiotensin II-mediated vasoconstriction and aldosterone secretion leads to further vasodilation and decreased sodium and water reabsorption in the renal tubules. The combined effect of these two molecular pathways is a systemic decrease in vascular resistance and plasma volume, resulting in a net hypotensive effect and modulation of central aortic pressure.

Dosage and Administration Information

How to Use Ascot: Official Administration Guidelines

Ascot, a combination product containing Acetylsalicylic Acid (ASA) and Ascorbic Acid (Vitamin C), is intended for oral administration only. Its official usage is structured around specific dosage limits and preparation requirements.


Standard Dosing and Preparation

The medicine is typically supplied as an effervescent tablet, which must be fully dissolved in a glass of water before it is consumed. The standard single dose for an adult is 1 to 2 tablets (equivalent to 400 mg to 800 mg ASA). This dose may be repeated if necessary, maintaining a minimum interval of 4 to 8 hours between doses.

Administration is generally advised after a main meal or on a full stomach to adhere to guidelines for the NSAID component. It is critical that the maximum daily dose of 3,200 mg ASA (typically 8 tablets) is not exceeded within any 24-hour period.


Usage Duration and Population Rules

Ascot is designated for short-term use for the management of acute symptoms. The protocol mandates that use should generally be limited to no more than 3 to 4 days. If symptoms persist or worsen beyond this duration, administration must cease, and professional advice should be sought.

Regarding specific patient populations, this combination product is not recommended for use in children or adolescents generally under the age of 12 or 16 due to the Acetylsalicylic Acid component. For older adults, official instructions emphasize the importance of using the lowest effective dosage.

Recent Clinical Evidence

Ascot: Recent Clinical Evidence

The primary source of data for the evaluation of this agent in treating hypertension and cardiovascular risk factors is the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), specifically its Blood Pressure Lowering Arm (BPLA). This large-scale, prospective, randomized study, which included over 19,000 participants, examined the effects of different blood pressure-lowering regimens.


Key Comparisons and Outcomes Studied

The ASCOT-BPLA trial primarily compared two treatment strategies in patients with hypertension and at least three other cardiovascular risk factors:

  1. Amlodipine-Based Regimen: A calcium channel blocker (amlodipine), with an Angiotensin-Converting Enzyme Inhibitor (perindopril) added as needed.
  2. Atenolol-Based Regimen: A beta-blocker (atenolol), with a diuretic added as needed.

While the trial was stopped early by the Data Safety Monitoring Board, the final analysis evaluated a number of clinical outcomes, including:

Outcome Category Comparison Studied
Cardiovascular Events Rates of non-fatal myocardial infarction and fatal coronary heart disease (the primary endpoint), stroke, and total cardiovascular events.
Secondary Benefits Incidence of new-onset type 2 diabetes mellitus and overall renal impairment.

Findings Summary

Studies focused on whether the amlodipine-based regimen was associated with a reduction in major cardiovascular outcomes and mortality compared to the atenolol-based regimen. The findings suggested a reduced incidence of fatal and non-fatal stroke, as well as a lower rate of new-onset type 2 diabetes mellitus in the group assigned to the amlodipine-based strategy. Studies also examined long-term follow-up to ascertain outcomes related to stroke and dementia.

Frequently Asked Questions (FAQ)

Common questions about Ascot (FAQ)


Q: Besides deficiency, what other conditions is Ascot commonly used to treat?

A: The primary therapeutic purpose of the Ascot combination product, according to official information, is to provide symptomatic relief.

It is commonly used to manage general discomfort such as pain and fever in adults.


Q: What is the mechanism of action for Ascot in preventing or treating scurvy?

A: Ascot contains Ascorbic Acid (Vitamin C), which is the key component for addressing scurvy.

While the specific biological mechanism is complex and not fully understood, the regulatory literature indicates that administration aims to restore the body’s essential pool of ascorbic acid to reverse the deficiency.


Q: Is Ascot intended for long-term daily use or only for short-term treatment?

A: Official patient information generally designates Ascot for short-term use for the management of acute symptoms.

Use is generally recommended for no more than three to four days at a time. If symptoms persist or worsen beyond this period, professional medical advice may be appropriate.


Q: Are there any serious, but rare, side effects associated with Ascot use?

A: While side effects are generally mild, official safety documentation highlights the risk of serious, rare events, mainly due to the Aspirin component.

These include the development of gastrointestinal ulcers, which may sometimes lead to perforation (a hole in the stomach or intestines) and gastrointestinal bleeding.


Q: Does taking Ascot affect the results of laboratory tests like urine glucose screens?

A: Yes, regulatory documents indicate that the Ascorbic Acid component of Ascot can interfere with the results of certain laboratory tests.

This interference can affect the biochemical determination of substances like creatinine, uric acid, and glucose in laboratory samples.


Q: Is there a risk of kidney stones when taking high doses of Ascot?

A: High-dose use of products containing the Ascorbic Acid component has been associated with the development of oxalate and urate kidney stones in rare cases.

Official information indicates that this is a risk to be aware of.


Q: Is Ascot safe for use during pregnancy or while breastfeeding?

A: Official warnings state that use of the Acetylsalicylic Acid component must be avoided from 20 weeks of gestation onward due to potential risks to the fetus.

It is also officially contraindicated in the third trimester of pregnancy, and official information often contraindicates the use of the product while breastfeeding.


Q: What is the difference in purpose between taking Ascot orally versus by injection?

A: The oral Ascot product (tablet form) is intended for the symptomatic relief of pain and fever.

Injectable forms of the Ascorbic Acid component are sometimes indicated for the short-term treatment of scurvy when the patient is unable to take the medicine by mouth.


Q: Does Ascot help with iron absorption, and why is that important?

A: Yes, official monographs confirm that Ascorbic Acid (Vitamin C) is involved in the process of iron absorption in the body.

This role is significant because iron is an essential mineral required for various body functions, including oxygen transport.


Q: Is Ascot considered an essential vitamin for the human body?

A: The Ascorbic Acid component of Ascot is classified as an essential micronutrient.

This means that the human body cannot produce it on its own and requires it from external sources, whether through diet or supplementation, for proper supportive functions.


Q: What are the signs of a Vitamin C deficiency that Ascot is meant to treat?

A: Ascot is sometimes used to supplement the body during Vitamin C deficiency, which, in its severe form (scurvy), presents distinct symptoms.

Regulatory documents list signs such as widespread skin changes, bleeding gums, poor wound healing, and capillary fragility.


Q: Is there any research suggesting Ascot is beneficial for skin health or wound healing?

A: The active ingredient Ascorbic Acid is known to be an essential cofactor for collagen biosynthesis.

Collagen is a critical component of connective tissue, and official literature states that a deficiency in Vitamin C results in poor wound healing.


Q: Does Ascot need to be refrigerated or how should it be properly stored?

A: Ascot should not be refrigerated.

Official storage requirements state that it must be kept at controlled room temperature (typically between 15 C and 30 C), and must be protected from moisture, light, and excessive heat.


Q: Is it safe to take Ascot if I am a smoker or have a history of alcoholism?

A: Official warnings specify that the combination of the Acetylsalicylic Acid component with chronic, heavy Alcohol use is explicitly linked to an increased risk of gastrointestinal bleeding.

Patients with a history of chronic alcohol use should discuss this risk with a healthcare provider.


Q: Does Ascot interact with herbal supplements or natural remedies?

A: Yes, regulatory warnings highlight potential interactions with certain herbal supplements.

Specifically, the official literature notes that herbal products such as Ginkgo and Garlic may increase the risk of hemorrhage (excessive bleeding) when combined with the Aspirin component.


Q: Why do people sometimes take Ascot to help with urinary acidification?

A: The Ascorbic Acid component of this product has the ability to acidify the urine.

While this is not the product’s primary intended purpose, this change in pH can sometimes affect the renal excretion (how the body eliminates) of certain other drugs.


Q: How does the body typically process and excrete the active ingredient in Ascot?

A: The Aspirin component is rapidly metabolized into salicylic acid and is primarily excreted as metabolites through the urine.

The Ascorbic Acid component is also excreted by the kidney; once its plasma concentration exceeds a certain threshold, the excess is eliminated through the urine.


Q: What is the relationship between Ascot and the controversial concept of 'conditional scurvy'?

A: This concept relates to the Ascorbic Acid component, where high doses taken over a prolonged period have been reported to potentially cause 'conditional scurvy' when suddenly stopped.

This phenomenon, though controversial and not universally accepted, suggests a potential concern associated with the cessation of long-term, high-dose use.


Q: What is the difference between Ascot capsules and extended-release tablets?

A: Official product labeling specifies that Ascot is formulated as an effervescent tablet.

Other specific dosage forms, such as capsules or extended-release tablets, are not detailed in the authorized product information.

How should Ascot be stored and disposed of?

How to Store and Dispose of Ascot

Official regulatory guidelines define specific conditions for storing and disposing of Ascot (Acetylsalicylic Acid and Ascorbic Acid) tablets.

Storage Requirements

Ascot must be stored at controlled room temperature, typically between 15 C and 30 C (59 F and 86 F). The product requires protection from moisture, excessive heat, and light to maintain its stability. Tablets must remain in the tightly closed original container. For safety, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Ascot must be disposed of according to local/national regulations for pharmaceutical waste. To protect the environment, the product should not be allowed to enter drains, sewers, or other waterways.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ascot found in:

A-Z Index: